You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:


Last Updated: September 29, 2023

Boehringer Ingelheim Company Profile

✉ Email this page to a colleague

« Back to Dashboard

Biologic Drugs for Boehringer Ingelheim

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim Pharmaceuticals, Inc. VERLUMA nofetumomab Injection 103769 1998-10-13 ⤷  Try a Trial
Boehringer Ingelheim Pharmaceuticals, Inc. PRAXBIND idarucizumab Injection 761025 2015-10-16 ⤷  Try a Trial
Boehringer Ingelheim Pharmaceuticals, Inc. CYLTEZO adalimumab-adbm Injection 761058 2017-08-25 ⤷  Try a Trial
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.